These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3467874

  • 1. Ofloxacin: therapeutic activity in experimental infections.
    Guerra L, Erani E, Xerri L.
    Chemioterapia; 1986 Dec; 5(6):375-8. PubMed ID: 3467874
    [Abstract] [Full Text] [Related]

  • 2. [Ofloxacin (RU 43280): clinical evaluation in urinary and prostatic infections].
    Guibert J, Acar JF.
    Pathol Biol (Paris); 1986 May; 34(5):494-7. PubMed ID: 3534729
    [Abstract] [Full Text] [Related]

  • 3. [Results of ofloxacin treatment of experimental urinary tract infections].
    Ritzerfeld W.
    Infection; 1986 May; 14 Suppl 1():S45-6. PubMed ID: 3514471
    [Abstract] [Full Text] [Related]

  • 4. In vivo antibacterial activity of diaveridine-sulfonamide combinations.
    Carroll PT, Robb CA, Tippett LO, Langston JB.
    Invest Urol; 1971 Jul; 9(1):21-4. PubMed ID: 4935215
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T.
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [Abstract] [Full Text] [Related]

  • 6. Carbenicillin (Pyopen) in treatment of severe systemic infections and pyelonephritis due to Pseudomonas aeruginosa and Proteus.
    Liwski R, Gietko G.
    Pol Med J; 1970 Dec; 9(3):611-20. PubMed ID: 4989147
    [No Abstract] [Full Text] [Related]

  • 7. [Experience with nalidixic acid in pyelonephritis in children].
    Zapp E.
    Arch Kinderheilkd; 1968 Apr; 177(1):53-60. PubMed ID: 4880029
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the use of ofloxacin in the treatment of various infections].
    Peyramond D, Tigaud S, Lucht F, Vedrinne JM, Salord F, Bertrand JL.
    Pathol Biol (Paris); 1986 May; 34(5):471-5. PubMed ID: 3534724
    [Abstract] [Full Text] [Related]

  • 9. Pyelonephritis in the mouse. 3. Therapeutic experiments.
    FitzPatrick FK, Bladzinski J.
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1180-5. PubMed ID: 4297698
    [No Abstract] [Full Text] [Related]

  • 10. [Carbenicillin treatment of Pseudomonas aeruginosa infections and Proteus infections in infants].
    Korányi G, Pesti E.
    Acta Paediatr Acad Sci Hung; 1972 Apr; 13(4):345-56. PubMed ID: 4198126
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic contribution of the new quinolones].
    Wolff M.
    Rev Prat; 1987 Apr 11; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract] [Full Text] [Related]

  • 12. [Urinary tract infections: risk factors and therapeutic trends].
    Margariti PA, Astorri AL, Mastromarino C.
    Recenti Prog Med; 1997 Feb 11; 88(2):65-8. PubMed ID: 9148368
    [Abstract] [Full Text] [Related]

  • 13. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
    Rudzit EA, Lisitsa LI.
    Farmakol Toksikol; 1971 Feb 11; 34(2):246-50. PubMed ID: 4998195
    [No Abstract] [Full Text] [Related]

  • 14. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug 11; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]

  • 15. [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents].
    Sukhodol'skaia AE, Chaĭkovskaia VL.
    Antibiotiki; 1974 Jul 11; 19(7):630-3. PubMed ID: 4618771
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Use of ofloxacin in otorhinolaryngologic infections].
    Forno-Pizzoglio M, Cuffini AM, Carlone NA, Cavallo GP.
    G Batteriol Virol Immunol; 1986 Jul 11; 79(1-6):154-60. PubMed ID: 3479369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue concentrations of ofloxacin in the middle ear.
    Thorn V.
    Clin Ther; 1987 Jul 11; 9(5):523-7. PubMed ID: 3478138
    [Abstract] [Full Text] [Related]

  • 20. Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.
    Rubinstein E, Mark Z, Keren G, Alkan M, Berger S, Bogokowski B.
    Infection; 1986 Jul 11; 14 Suppl 1():S20-5. PubMed ID: 3514469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.